Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020. https://doi.org/10.1038/s41582-019-0284-z.

Article  PubMed  Google Scholar 

Marsicano G, Lutz B. Neuromodulatory functions of the endocannabinoid system. J Endocrinol Invest. 2006;29(3 Suppl):27–46.

CAS  PubMed  Google Scholar 

Skaper SD, Di Marzo V. Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos Trans R Soc Lond B Biol Sci. 2012. https://doi.org/10.1098/rstb.2012.0313.

Article  PubMed  PubMed Central  Google Scholar 

Busquets Garcia A, Soria-Gomez E, Bellocchio L, Marsicano G. Cannabinoid receptor type-1: breaking the dogmas. F1000Res. 2016. https://doi.org/10.12688/f1000research.8245.1.

Article  PubMed  PubMed Central  Google Scholar 

Busquets-Garcia A, Desprez T, Metna-Laurent M, Bellocchio L, Marsicano G, Soria-Gomez E. Dissecting the cannabinergic control of behavior: the where matters. BioEssays. 2015. https://doi.org/10.1002/bies.201500046.

Article  PubMed  Google Scholar 

Marsicano G, Lafenetre P. Roles of the endocannabinoid system in learning and memory. Curr Top Behav Neurosci. 2009. https://doi.org/10.1007/978-3-540-88955-7_8.

Article  PubMed  Google Scholar 

Busquets-Garcia A, Gomis-Gonzalez M, Guegan T, Agustin-Pavon C, Pastor A, Mato S, et al. Targeting the endocannabinoid system in the treatment of fragile X syndrome. Nat Med. 2013. https://doi.org/10.1038/nm.3127.

Article  PubMed  Google Scholar 

Navarro-Romero A, Vazquez-Oliver A, Gomis-Gonzalez M, Garzon-Montesinos C, Falcon-Moya R, Pastor A, et al. Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome. Neurobiol Dis. 2019. https://doi.org/10.1016/j.nbd.2019.01.014.

Article  PubMed  Google Scholar 

Benard G, Massa F, Puente N, Lourenco J, Bellocchio L, Soria-Gomez E, et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci. 2012. https://doi.org/10.1038/nn.3053.

Article  PubMed  Google Scholar 

Djeungoue-Petga MA, Hebert-Chatelain E. Linking mitochondria and synaptic transmission: the CB1 receptor. BioEssays. 2017. https://doi.org/10.1002/bies.201700126.

Article  PubMed  Google Scholar 

Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, et al. A cannabinoid link between mitochondria and memory. Nature. 2016. https://doi.org/10.1038/nature20127.

Article  PubMed  Google Scholar 

Soria-Gomez E, Pagano Zottola AC, Mariani Y, Desprez T, Barresi M, Bonilla-Del Rio I, et al. Subcellular specificity of cannabinoid effects in striatonigral circuits. Neuron. 2021. https://doi.org/10.1016/j.neuron.2021.03.007.

Article  PubMed  Google Scholar 

Busquets-Garcia A, Bains J, Marsicano G. CB(1) receptor signaling in the brain: extracting specificity from Ubiquity. Neuropsychopharmacology. 2018. https://doi.org/10.1038/npp.2017.206.

Article  PubMed  Google Scholar 

Duarte FV, Ciampi D, Duarte CB. Mitochondria as central hubs in synaptic modulation. Cell Mol Life Sci. 2023. https://doi.org/10.1007/s00018-023-04814-8.

Article  PubMed  PubMed Central  Google Scholar 

D’Antoni S, de Bari L, Valenti D, Borro M, Bonaccorso CM, Simmaco M, et al. Aberrant mitochondrial bioenergetics in the cerebral cortex of the Fmr1 knockout mouse model of fragile X syndrome. Biol Chem. 2020. https://doi.org/10.1515/hsz-2019-0221.

Article  PubMed  Google Scholar 

Valenti D, de Bari L, De Filippis B, Henrion-Caude A, Vacca RA. Mitochondrial dysfunction as a central actor in intellectual disability-related diseases: an overview of Down syndrome, autism, Fragile X and Rett syndrome. Neurosci Biobehav Rev. 2014. https://doi.org/10.1016/j.neubiorev.2014.01.012.

Article  PubMed  Google Scholar 

Valenti D, Manente GA, Moro L, Marra E, Vacca RA. Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. Biochem J. 2011. https://doi.org/10.1042/BJ20101908.

Article  PubMed  Google Scholar 

Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007. https://doi.org/10.1016/j.neuron.2007.10.001.

Article  PubMed  Google Scholar 

Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002. https://doi.org/10.1002/mrdd.10020.

Article  PubMed  Google Scholar 

Golubiani G, van Agen L, Tsverava L, Solomonia R, Muller M. Mitochondrial proteome changes in Rett Syndrome. Biology (Basel). 2023. https://doi.org/10.3390/biology12070956.

Article  PubMed  Google Scholar 

Cosentino L, Vigli D, Franchi F, Laviola G, De Filippis B. Rett syndrome before regression: a time window of overlooked opportunities for diagnosis and intervention. Neurosci Biobehav Rev. 2019. https://doi.org/10.1016/j.neubiorev.2019.05.013.

Article  PubMed  Google Scholar 

Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A. Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol Cell Biol. 2006. https://doi.org/10.1128/MCB.01665-05.

Article  PubMed  PubMed Central  Google Scholar 

Valenti D, de Bari L, Vigli D, Lacivita E, Leopoldo M, Laviola G, et al. Stimulation of the brain serotonin receptor 7 rescues mitochondrial dysfunction in female mice from two models of Rett syndrome. Neuropharmacology. 2017. https://doi.org/10.1016/j.neuropharm.2017.04.024.

Article  PubMed  Google Scholar 

Cittadini C, Germinario EAP, Maroccia Z, Cosentino L, Maselli V, Gambardella L, et al. Effects of the rho GTPase-activating toxin CNF1 on fibroblasts derived from Rett syndrome patients: a pilot study. J Cell Mol Med. 2023. https://doi.org/10.1111/jcmm.17624.

Article  PubMed  PubMed Central  Google Scholar 

Cortelazzo A, De Felice C, De Filippis B, Ricceri L, Laviola G, Leoncini S, et al. Persistent unresolved inflammation in the Mecp2-308 female mutated mouse model of Rett Syndrome. Mediators Inflamm. 2017. https://doi.org/10.1155/2017/9467819.

Article  PubMed  PubMed Central  Google Scholar 

Muller M, Can K. Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome. Biochem Soc Trans. 2014. https://doi.org/10.1042/BST20140071.

Article  PubMed  PubMed Central  Google Scholar 

De Filippis B, Valenti D, Chiodi V, Ferrante A, de Bari L, Fiorentini C, et al. Modulation of rho GTPases rescues brain mitochondrial dysfunction, cognitive deficits and aberrant synaptic plasticity in female mice modeling Rett syndrome. Eur Neuropsychopharmacol. 2015. https://doi.org/10.1016/j.euroneuro.2015.03.012.

Article  PubMed  Google Scholar 

Urbinati C, Cosentino L, Germinario EAP, Valenti D, Vigli D, Ricceri L, et al. Treatment with the bacterial toxin CNF1 selectively rescues cognitive and brain mitochondrial deficits in a female mouse model of Rett Syndrome carrying a MeCP2-Null mutation. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22136739.

Article  PubMed  PubMed Central  Google Scholar 

Urbinati C, Lanzillotta C, Cosentino L, Valenti D, Quattrini MC, Di Crescenzo L, et al. Chronic treatment with the anti-diabetic drug metformin rescues impaired brain mitochondrial activity and selectively ameliorates defective cognitive flexibility in a female mouse model of Rett syndrome. Neuropharmacology. 2023. https://doi.org/10.1016/j.neuropharm.2022.109350.

Article  PubMed  Google Scholar 

De Filippis B, Musto M, Altabella L, Romano E, Canese R, Laviola G. Deficient Purposeful Use of forepaws in female mice modelling Rett Syndrome. Neural Plast. 2015. https://doi.org/10.1155/2015/326184.

Article  PubMed  PubMed Central  Google Scholar 

Gomis-Gonzalez M, Busquets-Garcia A, Matute C, Maldonado R, Mato S, Ozaita A. Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in Fragile X Syndrome Mouse Model. Genes (Basel). 2016.